AM00898PU-N HIV-1 Gag Capsid protein p24 antibody

See related secondary antibodies

Search for all "HIV-1"

1 mg / €840.00
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Quick Overview

Mouse anti HIV-1 BDI489

AM00898PU-N

Product Description for HIV-1

Mouse anti HIV-1 BDI489.
Properties: Gag Capsid protein p24
Presentation: Purified
Product is tested for Enzyme Immunoassay, Immunocytochemistry/Immunofluorescence.

Properties for HIV-1

Product Category Primary Antibodies
Quantity 1 mg
Synonyms HIV-I, HIV1, Human immunodeficiency virus type 1
Presentation Purified
Applications E, ICC/IF
Clonality Monoclonal
Clone BDI489
Host Mouse
Isotype IgG1
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer OriGene Technologies GmbH
Material safety datasheet MSDS for Monoclonal Antibodies (de)

Datasheet Extract

Immunogen
Immunogen:
Recombinant Antigen
Property Gag Capsid protein p24
Isotype control AM03095PU-N
Application ELISA: 1:20 - 1:200.
IFA: 1:10 - 1:50.
Background HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90% of HIV1 infections belong to HIV1 group M.
Concentration 0,1 mg/ml (OD280nm, E0.1% = 1.4)
Storage Store the antibody at -20°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Purification:
>90% pure. Protein A chromatography
Buffer System:
0.01M PBS, pH 7.2 containing 0,09% sodium azide
State:
Liquid purified Ig
Purified
Specificity
Specificity:
This antibody recognizes HIV-1 p24 (native antigen).

Accessory Products

  • LinkedIn